The approval for the drug, which will be sold under the brand name Foundayo, marks an important technological inflection point for this class of drugs that is transforming obesity care in the US and around the world
Common Adverse Effects According to pharmaceutical research on semaglutide, gastrointestinal effects are most frequent: nausea (20-44% incidence, usually mild-moderate, improves over time), vomiting (9-24% incidence), diarrhea (20-30% incidence), constipation (20-24% incidence), and abdominal pain (8-20% incidence)
For immediate, short-lived relief, use fast-acting antacids or alginate-based products that form a foam barrier to reduce acid levels, and follow the product label for dosing
Furthermore, supplements are not FDA-regulated and may not be safe for everyone to take
One injection maintains elevated GH for a week
& Leibel, R